(0)

Our site is optimized for screen resolutions of 1024 x 768 and higher. We’ve detected yours is set below this. For the best experience, please adjust your resolution. To close this message click here

How Can We Help?

In The News

Randolph V. Clower Comment on Decisions Involved in Starting a Business  More

Phillips Lytle Participates at MedTech Conference in Rochester, New York  More

Randolph V. Clower Interviewed by The Metropolitan Corporate Counsel  More

View all for this attorney

Press Releases

Dr. Randolph V. Clower Participated in Cornell University’s “Broadening Experiences in Scientific Training” Event on March 18 in Ithaca  More

Dr. Randolph V. Clower is Inaugural Intellectual Property Mentor for the Crowdfunding Initiative MakerStaker.com  More

Dr. Randolph V. Clower Participates in 2013 “Becoming A Leader In Life Sciences” Series on the Buffalo Niagara Medical Campus  More

View all for this attorney

Speaking Engagements

Panelist, “Governance, Risk & Compliance”, Cornell University’s “Broadening Experiences in Scientific Training” (BEST), March 2014  More

Speaker, “Becoming a Leader in Life Sciences,” Buffalo Niagara Medical Campus, November 2013  More

Panelist, “America Invents Act,” 2013 SmartStart UNYTECH Venture Forum, May 2013  More

View all for this attorney

Publications

Author, “Top 5 Post AIA Implementation University Considerations,” IPWatchdog, June 2013  More

Author, “Impending Myriad Decision Portends Promethean Consequences For Biotech Industry,” The Metropolitan Corporate Counsel, March 2013  More

Author, “Are Human Genes Patentable?” Phillips Lytle Intellectual Property Client Alert, December 2012  More

View all for this attorney

Randolph V. Clower, Ph.D., J.D.
Associate, Buffalo
(716) 847-5421
rclower@phillipslytle.com

Dr. Clower focuses his practice in the area of intellectual property where he possesses a breadth of experience concerning worldwide patent procurement, including prosecuting and preparing patent applications in the fields of microbiology, immunology, oncology, cancer therapeutics, molecular/cellular biology, pharmaceuticals, vaccine biology, DNA_RNA and molecular diagnostics, theranostics, personalized medicine, medical devices, small_molecule inhibitors, drug discovery and development, hydrogel technology, tissue engineering, cell/cell-sheet and stem cell technologies, high-throughput and industrial biologics applications, and various other biotechnology/chemical areas.

He also prepares non-infringement/invalidity opinions, freedom-to-operate assessments, and patentability evaluations for individual inventors, university clients, small biotechnology companies, and FORTUNE® 500 clients.

Prior to joining Phillips Lytle, Dr. Clower was a patent attorney at Foley & Lardner, LLP and LeClairRyan, PC. He also previously assisted the University at Buffalo Office of Science, Technology Transfer and Economic Outreach (STOR) by drafting patentability assessments.

Frequently engaged with the scientific community, Dr. Clower allocates time to volunteering as IP counsel for the local Pre-Seed Workshops and business plan competitions, while also lecturing about the changing landscape of U.S. and international patent law. Dr. Clower has been a “featured author” on JD Supra, drafted articles and comments for IPWatchdog.com, Law 360, Buffalo Niagara Enterprise, the Journal of Virology, and Virology.

Dr. Clower is also involved with the medical device and regulatory communities by sitting on the advisory board of a medical manufacturing and FDA regulatory compliance company, while additionally serving as an IP mentor for various start-up funding initiatives.

Dr. Clower served as a graduate research fellow during law school, where he was the recipient of the 2009 ABA and BNA Award for Excellence in the study of IP law and the 2008 Harold A. Dautch Memorial Scholarship. Dr. Clower received his doctorate in microbiology and immunology, and was the recipient of the NIH Pre-Doctorate Training Grant Fellowship for microbial pathogenesis during his graduate education. He earned his bachelors degree in recombinant gene technology while also obtaining a minor in chemistry.

EDUCATION

State University of New York at Buffalo School of Law, J.D., cum laude, 2009
State University of New York at Buffalo School of Medicine and Biomedical Sciences, Ph.D., 2006
State University of New York at Fredonia, B.S., summa cum laude, 2001

ADMITTED TO PRACTICE

New York
Wisconsin
U.S. Patent and Trademark Office - Registered Patent Attorney

PRESENT ACTIVITIES

  • MakerStaker Mentor Program, Intellectual Property Mentor